[1]
N. Ebrahim, T. Eissa, M. Hussein, A. Arafat, and N. Amin, “Toward Precision Oncology in Ovarian Cancer: Dual PD-L1 and CD44 Biomarker Profiling for Recurrence Risk Assessment”, apjcb, vol. 10, no. 3, pp. 689-698, Aug. 2025.